Caitong International Asset Management Co., LTD Stoke Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 59 shares of STOK stock, worth $630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 59
-0.0%
Holding current value
$630
Previous $651,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STOK
# of Institutions
135Shares Held
57.3MCall Options Held
5.7KPut Options Held
24.4K-
Skorpios Trust6.91MShares$73.8 Million99.8% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$57.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$55.4 Million22.22% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$54.7 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$49.5 Million0.57% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $421M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...